Product Recalls: January 15, 2020 – February 12, 2020

Health Letter, March 2020


Atorvastatin calcium tablets, 10 mg, 90-count bottle. Manufactured for: Biocon Pharma Inc.

Desmopressin acetate tablets, 0.1 or 0.2 mg, 100-count bottle. Manufactured by: Actavis Laboratories, Inc.

Dutasteride capsules, 0.5 mg, 30 capsules (6 X 5) per carton. Manufactured for: AvKARE, Inc.

Liothyronine (T3) capsules, 80 or 92.5 mcg. MPRX, Inc.

Naltrexone capsules, 4.5 mg. MPRX, Inc.

Nizatidine capsules, 150 or 300 mg. Manufactured by: Mylan Pharmaceuticals Inc.

Olmesartan medoxomil tablets, 20 mg, 90-tablet bottle. Manufactured by: Alkem Laboratories Ltd.

Progesterone capsules, 50 or 100 mg. MPRX, Inc.

Ranitidine tablets; 150 or 300 mg; 4-, 7-, 14-, 15-, 20-, 24-, 30-, 60-, 90- or 100-count bottle or package. Manufactured by: H.J. Harkins Company, Inc. or Preferred Pharmaceuticals, Inc. or Repackaged by: Northwind Pharmaceuticals.

Ranitidine hydrochloride tablets; 150 mg; 14-, 30-, 60-, 90- or 100-count bottle. Distributed by: PD-Rx Pharmaceuticals Incorporated.

Sildenafil capsules, 80 mg. MPRX, Inc.

Sumatriptan succinate tablets, 50 or 100 mg, packaged in 9 (1×9) unit-of-use blister card or 100-count bottle. Manufactured by: Sun Pharma.

T3/T4 SR capsule, 9 mcg/38 mcg. MPRX, Inc.

Tadalafil capsules, 6 mg. MPRX, Inc.

For more information about the drug recalls listed above, please visit


For a list of recent recalls of consumer products, please visit the Consumer Product Safety Commission website at